Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
229
-
Total 13F shares, excl. options
-
53.7M
-
Shares change
-
+11M
-
Total reported value, excl. options
-
$2.44B
-
Value change
-
+$526M
-
Put/Call ratio
-
0.94
-
Number of buys
-
169
-
Number of sells
-
-55
-
Price
-
$45.36
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2017
297 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2017.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 229 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.7M shares
of 106M outstanding shares and own 50.87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.23M shares), VANGUARD GROUP INC (4.94M shares), STATE STREET CORP (2.92M shares), CITADEL ADVISORS LLC (2.04M shares), FMR LLC (2.02M shares), Point72 Asset Management, L.P. (1.65M shares), Tourbillon Capital Partners, L.P. (1.53M shares), DEUTSCHE BANK AG\ (1.45M shares), FRED ALGER MANAGEMENT INC (1.43M shares), and Camber Capital Management LLC (1.4M shares).
This table shows the top 229 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.